We are seeking an exceptional Sales Representative to lead the commercial launch of our groundbreaking in vivo CRISPR therapy for hereditary angioedema (HAE). This rolerepresentsa career definingopportunity to pioneer the commercialization of the first-ever, single treatment gene editing therapy. The successful candidate willbe responsible forintroducing healthcare providers to the first-ever in vivo CRISPR therapy, requiring sophisticated scientific communication, complex stakeholder management, and exceptional execution within a highly competitive rare disease market. This territory will cover Oklahoma, Kansas, Nebraska. How You Will Achieve More: Responsibilities: Territory Management & Account Development 37 Territory Planning: Develop and execute comprehensive territory plans targeting immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers 37 Account Prioritization: Identify and prioritize high-value accounts based on HAE patient volume, prescriber influence, and institutional capabilities 37 Relationship Building: Establish trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makers 37 Pipeline Management: Maintain robust sales pipeline tracking opportunities from initial awareness through patient treatment completion Scientific Education & Communication 37 CRISPR Technology Education: Educate healthcare providers on in vivo CRISPR gene editing mechanisms, differentiating from ex vivo cell therapies and traditional treatments 37 MOA Differentiation: Clearly articulate the unique mechanism of action compared to prophylactic treatments, complement inhibitors, and plasma-derived therapies 37 Clinical Data Presentation: Present Phase III efficacy and safety data 37 Technology Positioning: Address misconceptions about CRISPR safety and differentiate from previous gene therapy launches 37 Disease Education:educatehealthcare providers about unmet needs affecting disease management and treatment burden Competitive Differentiation 37 Competitive Intelligence: Maintain deep understanding of competitive landscape and emerging therapies 37 Value Proposition Development: Articulate differentiated value propositions versus existing HAE treatments and other gene therapies 37 Objection Handling: Proactively address concerns about CRISPR technology, permanent genetic modification, and single-treatment cost 37 **Company Differentiation**: Position organization as innovative leader with superior clinicalacumen Complex Treatment Pathway Management 37 Patient JourneyEducation:Educate on thepatient pathway from diagnosis confirmation through treatment administration 37 Hub Services Integration:Coordinatewith patient support hubs to ensure seamless patient experience and treatment access Cross-Functional Collaboration 37 Medical Affairs Partnership: Coordinate with Medical Science Liaisonsto seamlessly address customers9 medical and clinical informational needs 37 Market Access Alignment: Work closely with Field Reimbursement Managers on payer strategy andcoverage optimization 37 Strategic Accounts:Partnerwith strategic accounts team to understand referral patterns, site selection, and site activation for procurement and administration of the therapy About You: Scientific & Technical Knowledge 37 HAE Understanding: Comprehensive knowledge of hereditary angioedema pathophysiology, treatment landscape, and unmet medical needs 37 CRISPR/Gene Therapy Familiarity: Understanding of gene editing technologies, genetic medicines, and regulatory requirements 37 **Clinical Data Interpretation**: Ability to analyze and present complex clinical trial data and real-world evidence Skills & Competencies 37 Scientific Communication: Exceptional ability to communicate complex scientific concepts to diverse healthcare audiences 37 Customer Alignment &Relationship Management: Proven ability to build andmaintainlong-term relationships with key stakeholders 37 Problem Solving: Creative approach to overcoming access barriers and treatment implementation challenges 37 Collaboration and Learning: nurtures internal relationships andfacilitatescollaborationtoestablishtrust and support from others. 37 Growth Mindset: Remain open to change anddemonstratesa willingness to trynew approachesto achieve better results 37 Competitive Mindset: Engages in bold conversations, handles objections, and asks forthe business 37 Execution and Results:Demonstratesa businessownermindset andtakes action to exceedexpectations. Develops andexecutes ona comprehensivebusiness plan to maximize customer and patient impact Personal Attributes 37 Innovation Mindset: Passion for pioneering new treatment paradigms and improving patient outcomes 37 Resilience: Ability to persist through lengthy sales cycles and overcome technology-related objections 37 Adaptability: Flexibility to adjust strategies based on market feedback and competitive dynamics 37 Integrity: Unwavering commitment to ethical sales practices and regulatory compliance 37 Patient Focus: Genuine commitment to improving lives of patients with rare genetic diseases 37 BS/BA in life sciences or a business-related field 37 Rare Disease, Gene therapy, and HAE market knowledge preferred but not necessary 37 Sales Experience: 5+ years of specialty pharmaceutical sales experience, preferably in rare diseases, immunology, or genetic medicines 37 Rare Disease Expertise: Proven track record in rare disease commercialization with complex treatment paradigms and small patient populations 37 Launch Experience: Previous experience with product launches, particularly first-in-class or novel mechanism therapies 37 Complex Sales Environment: Demonstrated success in long sales cycles (12-18 months) with multiple stakeholders and high-value transactions #LI-Remote The base salary for this position is expected to range between $166,500.00 - $203,500.00 USD per year. The salary offered is determined based on a range of factors including, but not limited to, relevant education and training, overall related experience, specialized, rare or in-demand skill sets, internal comparators and other business needs. Upon joining Intellia, your salary will be reviewed periodically and additional factors such as time in role and performance will be considered. Intellia may change the published salary range based on company and market factors. Additional compensation includes a performance-based annual cash bonus, a new hire equity grant, and eligibility to be considered for annual equity awards the value of which are determined annually at the Company9s discretion. For more information about Intellia9s benefits, please .